Blue Trust’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Blue Trust's PACB Position: Q3 2026 in Review
Blue Trust opened a new position in Pacific Biosciences (PACB) in Q3 2026: 28 shares worth $65. The stake represents ﹤0.01% of the portfolio and ranks #2450 among its holdings. This is a return to the name: Blue Trust previously reported a position in PACB as recently as Q3 2024.
Blue Trust first reported a position in PACB in Q2 2022 and has held it in 8 quarters since. The position peaked at $15.3K in Q2 2024. 149 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Blue Trust held 28 shares of Pacific Biosciences worth $65 as of Q3 2026.
- Pacific Biosciences was a new Blue Trust position in Q3 2026.
- Pacific Biosciences made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2450 holding.
- Blue Trust first reported a position in Pacific Biosciences in Q2 2022 and has held it in 8 quarters since.
- Blue Trust's Pacific Biosciences position peaked at $15.3K in Q2 2024.
- 149 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.